IL-23 gene expression was shown to be increased in the pancreatic islet cells of a patient with type 1 diabetes, and targeting both the IL-23p19 and IL-12/IL-23p40 subunits has been shown to suppress the incidence of diabetes in nonobese diabetic mice (115, 116). This evidence concerns the gene IL23A and type 1 diabetes mellitus.